ЕНДОТЕЛІАЛЬНА ДИСФУНКЦІЯ ТА АРТЕРІАЛЬНА ГІПЕРТЕНЗІЯ (ОГЛЯД ЛІТЕРАТУРИ)
DOI:
https://doi.org/10.24061/1727-4338.XVI.1.59.2017.36Ключові слова:
ендотелій, оксид азоту, ендотеліальна дисфункція, артеріальна гіпертензіяАнотація
Наводяться дані літератури про функції ендотелію, механізми розвитку ендотеліальної дисфункції у хворих на артеріальну гіпертензію.Посилання
Ambrosova TN. Jendotelial'naja disfunkcija pri gipertonicheskoj bolezni [Endothelial dysfunction in hypertensive disease]. Mezhdunardnyj medicinskij zhurnal. 2013(4):16-21. (in Russian).
Babushkina AV. L-arginin s tochki zrenija dokazatel'noj mediciny [L-arginine in terms of evidence-based medicine]. Ukrains'kyi medychnyi chasopys. 2009;6:1-6. (in Russian).
Bileckij SV, Bileckij SS. Jendotelial'naja disfunkcija i patologija serdechno-sosudistoj sistemy [Endothelial dysfunction and pathology of the cardiovascular system]. Vnutrennjaja medicina. 2008;8(2):36-41. (in Russian).
Bilets'kyi SV. Insulinorezystentnist' yak skladova patohenezu arterial'noi hipertenzii [Insulin resistance as a component of the pathogenesis of arterial hypertension]. Bukovyns'kyi medychnyi visnyk.2015;19(2) 216-19. (in Ukrainian).
Bobrov VA, Firsova IG. Metabolizm oksida azota i jendotelial'naja disfunkcija u bol'nyh s jessencial'noj gipertenziej c priznakami remodelirovanija levogo zheludochka [Nitric oxide metabolism and endothelial dysfunction in patients with essential hypertension with signs of remodeling of the left ventricle]. Ukrains'kyi kardiolohichnyi zhurnal. 2010;3:58-63. (in Russian).
Vizir VA, Berezin AE. Rol' jendotelial'noj disfunkcii v formirovanii i progressirovanii arterial'noj gipertenzii. Prognosticheskoe znachenie i perspektivy lechenija [The role of endothelial dysfunction in the formation and progression of arterial hypertension. Prognostic significance and prospects of treatment]. Ukrains'kyi medychnyi chasopys. 2000;4:23-33. (in Russian).
Gerasimchuk NN. Vazoaktivnyj pul oksida azota u bol'nyh s arterial'noj gipertenziej i izbytochnoj massoj tela [The vasoactive nitric oxide pool in patients with hypertension and overweight]. Krovoobih ta hemostaz. 2008;3:21-6. (in Russian).
Get'man OI, Girin VV. Dinamika pokazatelej soderzhanija oksida azota i produktov perekisnogo okislenija lipidov u bol'nyh s arterial'noj gipertenziej [Dynamics of nitrogen oxide and lipid peroxidation products in patients with arterial hypertension]. Ukrains'kyi terapevtychnyi zhurnal. 2011;3:89-92. (in Russian).
Golovchenko JuI, Treshhinskaja MA. Obzor sovremennyh predstavlenij ob jendotelial'noj disfunkcii [Overview of modern concepts of endothelial dysfunction]. Consilium medicum Ukraina. 2008;11:38-40. (in Russian).
Denysiuk VI, Khrebtii HI. Endotelial'na dysfunktsiia ta insulinorezystentnist' u patsiientiv z arterial'noiu hipertenziieiu – «dvi storony odniiei medali» [Endothelial dysfunction and insulin resistance in patients with arterial hypertension - "two sides of one medal"]. Сonsilium medicum Ukraina. 2011;5:3-5. (in Ukrainian).
Zalesskij VN, Dynnik OB. Apoptoz – zavisimaja disfunkcija jendotelija i ateroskleroz [Apoptosis - dependent endothelial dysfunction and atherosclerosis]. Krovoobih ta hemostaz. 2003;2:22-8. (in Russian).
Zejnalov FM. Vzaimosvjaz' funkcional'nogo sostojanija jendotelija i aktivnosti citokinov pri rezistentnoj gipertonicheskoj bolezni, oslozhnennoj i neoslozhnennoj serdechnoj nedostatochnost'ju [Interrelation of the functional state of the endothelium and the activity of cytokines in resistant hypertensive disease, complicated and uncomplicated heart failure]. Vrachebnaja praktika. 2003;1:94-8. (in Russian).
Zagidullin NSh, Valeeva KF, Gassanov N, Zagidullin ShZ. Znachenie disfunkcii jendotelija pri serdechno-sosudistyh zabolevanijah i metody ee medikamentoznoj korrekcii [The importance of endothelial dysfunction in cardiovascular diseases and methods of its medicamental correction]. Kardiologija. 2010;5:54-9. (in Russian).
Zotova IV, Zatejshhikov DA, Sidorenko BA. Sintez oksida azota i razvitie ateroskleroza [Synthesis of nitric oxide and the development of atherosclerosis]. Kardiologija. 2002;4:58-67 (in Russian).
Korzh AN. Sovremennye predstavlenija o strukture, funkcii i biologicheskoj roli sosudistogo jendotelija [Modern ideas about the structure, function and biological role of the vascular endothelium]. Mezhdunardnyj medicinskij zhurnal.2003;1:130-34. (in Russian).
Korkushko OV, Lishnevskaja VJu. Jendotelial'naja disfunkcija [Endothelial dysfunction]. Krovoobih ta hemostaz. 2003;2:4-15. (in Russian).
Kuz'minova NV, Serkova VK. Funkcional'noe sostojanie sosudistogo jendotelija u bol'nyh gipertonicheskoj bolezn'ju [Functional state of vascular endothelium in patients with essential hypertension]. Ukrains'kyi terapevtychnyi zhurnal. 2008;2:21-7. (in Russian).
Lishnevskaja VJu. Jendotelial'naja funkcija i vozrast [Endothelial function and age]. Vrachebnaja praktika. 2003;4:5-10. (in Russian).
Malaja LT. Korzh AN, Balkovaja LB. Jendotelial'naja disfunkcija pri patologi serdechno-sosudistoj sistemy [Endothelial dysfunction in pathologists of the cardiovascular system]. Har'kov: Forsing; 2000. 432 s. (in Russian).
Markov HM. Rol' oksida azota v patogeneze boleznej detskogo vozrasta [Role of nitric oxide in the pathogenesis of childhood diseases]. Rossijskij vestnik perinatologii i pediatrii. 2000;4: 43-47. (in Russian).
Nebieridze DV. Klinicheskoe znachenie disfunkcii jendotelija pri arterial'noj gipertonii [Clinical significance of endothelial dysfunction in arterial hypertension]. Сonsilium medicum: Sistemnye gipertenzii. 2005;1:31-8. (in Russian).
Bilets'kyi SV, Koval'chuk LIu, Petrynych OA, Kazantseva TV. Pokaznyky prooksydantno-antyoksydantnoho homeostazu ta vmist monooksydu nitrohenu u krovi khvorykh na hipertonichnu khvorobu v poiednanni z ishemichnoiu khvoroboiu sertsia [Indicators of prooxidant antioxidant homeostasis and the content of nitrogen monoxide in the blood of patients with hypertension in combination with ischemic heart disease]. Bukovyns'kyi medychnyi visnyk. 2013;17(3 ч 2):125-28. (in Ukrainian).
Yakovleva OI, Vakhromiieva IV, Larionova VI. Polimorfizm hena endotelial'noi NO-syntazy i strukturno-funktsional'nyi stan velykykh sudyn u khvorykh na hipertonichnu khvorobu z hipertrofiieiu livoho shlunochka [Polymorphism of the endothelial NO synthase gene and the structural and functional state of large vessels in patients with hypertension with left ventricular hypertrophy]. Arterial'na hipertenziia. 2005;11(3):195-200. (in Ukrainian).
Ljamina NP, Senchihin VN, Podkidyshev DA. Prediktory disfunkcii jendotelija u lic molodogo vozrasta s vysokim normal'nym AD [Predictors of endothelial dysfunction in young adults with high normal blood pressure]. Kardiologija SNG.2003;1:177-78. (in Russian).
Kalinkina NV, Kashanskaja OK, Keting EV. Remodelirovanie arterij pri serdechno-sosudistyh zabolevanijah [Remodeling of arteries in cardiovascular diseases]. Serdce i sosudy. 2004;4:87-91. (in Russian).
El'skij VN, Vatutin NT, Kalinkina NV. Rol' disfunkcii jendotelija v geneze serdechno-sosudistyh zabolevanij [The role of endothelial dysfunction in the genesis of cardiovascular diseases]. Zhurnal Natsional'noi akademii medychnykh nauk Ukrainy. 2008; 14:51-62. (in Russian).
Storozhakov GI, Vereshhagina GS, Malysheva NV. Jendotelial'naja disfunkcija pri arterial'noj gipertonii u pacientov pozhilogo vozrasta [Endothelial dysfunction in hypertension in elderly patients]. Klinicheskaja gerontologija.2003;9(1):23-8. (in Russian).
Tishhenko MV. Pokazateli obmena aktivnyh form kisloroda i oksida azota u lic s povyshennym arterial'nym davleniem [Indicators of the exchange of active forms of oxygen and nitric oxide in people with high blood pressure]. Ukrains'kyi biokhimichnyi zhurnal. 2005;77(2):130-35. (in Russian).
Ljusov VA, Metel'skaja VA, Oganov RG. Evsikov EM, Teplova NV. Uroven' oksida azota v syvorotke perifericheskoj krovi bol'nyh s razlichnoj tjazhest'ju arterial'noj gipertenzii [The level of nitric oxide in the serum of peripheral blood of patients with different severity of arterial hypertension]. Kardiologija.2011;51(12):23-8. (in Russian).
Hajutin VM. Mehanorecepcija jendotelija arterial'nyh sosudov i mehanizmy zashhity ot razvitija gipertonicheskoj bolezni [Mechanotherapy of endothelium of arterial vessels and mechanisms of protection from the development of hypertensive disease]. Kardiologija.1996;7:27-35. (in Russian).
Chazov EI, Chazova IE. Rukovodstvo po arterial'noj gipertonii [Manual on arterial hypertension]. Moskva: Media Medika;2005. 784 с. (in Russian).
Jushhuk EN, Vasjuk JuA, Hadzegova AB. Jendotelial'naja disfunkcija pri zabolevanijah serdechno-sosudistoj sistemy i metody ee korrekcii [Endothelial dysfunction in diseases of the cardiovascular system and methods of its correction]. Klinicheskaja farmakologija i terapija. 2005;14(3):85-8. (in Russian).
Bautista LE. Inflammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic and biological evidence. https://www.ncbi.nlm.nih.gov/pubmed/12692566">J Hum Hypertens. 2003 Apr;17(4):223-30.
Böger .H. The pharmacodynamics of L-arginine. https://www.ncbi.nlm.nih.gov/pubmed/17513442">J Nutr. 2007 Jun;137(6 Suppl 2):1650S-1655S .
Born G, Schwartz C. Vascular endothelium . Stuttgart: Schattauer; 1997. 390 p.
Bryan NS, Bian K, Murad F. Discovery of the nitric oxide signaling pathway and targets for drug development. Front Biosci (Landmark Ed). 2009 Jan 1;14:1-18.
Chatterjee A, Black SM, Catravas JD. Endothelial nitric oxide (NO) and its pathophysiologic regulation. Vascul Pharmacol. 2008 Oct-Dec;49(4-6):134-40. doi: 10.1016/j.vph.2008.06.008.
38. Félétou M, Vanhoutte PM. Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol. 2006 Sep;291(3):H985-1002.
Gkaliagkousi E, Ritter J, Ferro A. Platelet-derived nitric oxide signaling and regulation. Circ Res. 2007Sep 28;101(7):654-62. DOI:10.1161/CIRCRESAHA.107.158410
Gornik HL, Creager MA. Arginine and endothelial and vascular health. J Nutr. 2004 Oct;134(10 Suppl):2880S-2887S; discussion 2895S.
Grundy S. Age as a risk factor: you are as old as your arteries. https://www.ncbi.nlm.nih.gov/pubmed/10335762">Am J Cardiol. 1999 May 15;83(10):1455-7, A7.
42. Lüscher TF, Barton M. Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs. Circulation. 2000 Nov 7;102(19):2434-40.
Momboli JV, Vanhoutte PM. Endothelial function after converting-enzyme inhibition. Medicographia. 1996;18(1):35-40.
Barylski M, Kowalczyk E, Banach M, Ciecwierz J, Pawlicki L, Kowalski J. Plasma total antioxidant activity in comparison with plasma NO and VEGF levels in patients with metabolic syndrome. Angiology. 2009 Feb-Mar;60(1):87-92. doi: 10.1177/0003319708327165.
Tentolouris N, Liatis S, Katsilambros N. Sympathetic system activity in obesity and metabolic syndrome. Ann N Y Acad Sci. 2006 Nov;1083:129-52. DOI: 10.1196/annals.1367.010.
Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980 Nov 27;288(5789):373-6.
Thuillez C, Richard V. Targeting endothelial dysfunction in hypertensive subjects. J Hum Hypertens. 2005 Jun;19 Suppl 1:S21-5. DOI:10.1038/sj.jhh.1001889.
Wilkinson IB, McEniery CM. Arterial stiffness, endothelial function and novel pharmacological approaches. Clin Exp Pharmacol Physiol. 2004 Nov;31(11):795-9. DOI: 10.1111/j.1440-1681.2004.04074.x.
Zahedi Asl S, Ghasemi A, Azizi F. Serum nitric oxide metabolites in subjects with metabolic syndrome. Clin Biochem. 2008 Nov;41(16-17):1342-7. doi: 10.1016/j.clinbiochem.2008.08.076.
##submission.downloads##
Опубліковано
Номер
Розділ
Ліцензія
Авторське право (c) 2017 S. V. Biletskyi, V. V. Boyko, O. A. Petrynych, T. V. Kazantseva
Ця робота ліцензується відповідно до Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Часопис користується «Типовим шаблоном положення про авторські права».
